2
034
C. H o¨ o¨ g et al. / Carbohydrate Research 337 (2002) 2023–2036
Allyl 2-O-acetyl-3,4-di-O-benzoyl-a-
osyl-(12)-3,4-di-O-benzoyl-h- -rhamnopyranosyl-(1
3)-2,4-di-O-benzoyl-h- -rhamnopyranosyl-(12)-
3,4,6-tri-O-benzoyl-2-deoxy-2-phthalimido-i- -gluco-
pyranosyl-(13)]-4-O-benzoyl-h- -rhamnopyranoside
15).—Glycosylation of the tetrasaccharide 14 (1.26 g,
L
-rhamnopyran-
4-O-acetyl-h-L-rhamnopyranoside (16).—The protected
pentasaccharide 15 (1.20 g, 0.595 mmol) was dissolved
L
[
L
in CH Cl (5 mL) and MeOH (50 mL). The mixture
2
2
D
was stirred, and a solution of 1 M NaOMe in MeOH
(2.5 mL) was added. After 10 h at rt, an additional
aliquot of NaOMe–MeOH solution (1 mL) was added,
L
(
0
0
.777 mmol) with the trichloroacetimidate 12 (0.522 g,
.934 mmol) using the procedure previously described
and the reaction was kept under N for a further 36 h
2
at rt. Trituration with hexanes (ꢀ20 mL) produced a
white solid that was collected by filtration and washed
thoroughly with hexanes (2×30 mL). The dry solid
was dissolved in a mixture of EtOH (50 mL) and
for the preparation of 13 yielded the protected pen-
tasaccharide 15 as a colorless foam (1.38 g, 88%) after
purification by column chromatography (9:1 toluene–
2
0
1
EtOAc). [h]D +63° (c 0.74, CHCl ). H NMR (400
ethylenediamine (5 mL) and refluxed under N for 24 h.
3
2
MHz, CDCl ): l 8.45–6.90 (m, 54 H, Ar), 6.25 (dd, 1
The solvents were removed, and toluene (2×50 mL)
3
H, J2C,3C 10.5, J3C,4C 9.1 Hz, H-3C), 6.02 (dd, 1 H,
J4C,5C 10.1 Hz, H-4C), 5.85–5.75 (m, 1 H, CHꢀCH2),
was added and evaporated. The residue was treated
with Ac O (5 mL) and MeOH (50 mL) for 2 h at rt and
2
5
.74 (d, 1 H, J1C,2C 8.1 Hz, H-1C), 5.72 (d, 1 H, H-1A%),
.71 (dd, 1 H, J2B%,3B% 3.6, J3B%,4B% 10.0 Hz, H-3B%), 5.70
concentrated to give crude deprotected pentasaccharide
10. Purification by flash chromatography (6:3:1
5
(
1
dd, 1 H, J3A,4A 10.0 Hz, H-3A), 5.66 (dd, 1 H, J1A%,2A%
.6 Hz, H-2A%), 5.64 (t, 1 H, J3A%,4A%=J4A%,5A%=9.8 Hz,
H-4A%), 5.58 (t, 1 H, J3A,4A=J4A,5A=9.8 Hz, H-4A),
EtOAc–MeOH–H O) was not successful at completely
2
removing salts and aromatic impurities as evidenced by
1
H NMR, so the impure product was acetylated to
5
1
.50 (dd, 1 H, J1A,2A 2.0, J2A,3A 3.4 Hz, H-2A), 5.34 (dd,
H, H-2C), 5.34 (t, 1 H, J3B%,4B%=J4B%,5B%=9.7 Hz,
facilitate purification. After treatment with Ac O (15
2
mL), pyridine (15 mL) and DMAP (50 mg) for 3 h at
45 °C, the reagents were removed in vacuo, and the
residue was dissolved in EtOAc (75 mL) and washed
with water (30 mL), 1 M aq HCl (10 mL), satd
H-4B%), 5.33 (d, 1 H, J1B%,2B% 1.5 Hz, H-1B%), 5.31–5.25
(
(
m, 1 H, CHꢀCH ), 5.21–5.17 (m, 1 H, CHꢀCH ), 5.20
t, 1 H, J3B,4B=J4B,5B=9.8 Hz, H-4B), 4.80 (d, 1 H,
2
2
J1B,2B 1.3 Hz, H-1B), 4.70 (dd, 1 H, J6C,6%C 12.1, J5C,6C
NaHCO solution (30 mL) and satd NaCl solution (10
3
2.8 Hz, H-6C), 4.67 (dd, 1 H, J2A%,3A% 3.0 Hz, H-3A%),
4.63 (d, 1 H, J1A,2A 1.8 Hz, H-1A), 4.49 (dd, 1 H, J5C,6C
5.5 Hz, H-6%C), 4.40 (dd, 1 H, J2B,3B 3.5 Hz, H-2B), 4.32
mL). Purification by flash chromatography (EtOAc)
gave the acetylated pentasaccharide 16 as a colorless
20
1
foam (0.403 g, 51%). [h]D −50° (c 0.88, CHCl ). H
3
(
dq, 1 H, H-5A), 4.29 (ddd, 1 H, H-5C), 4.23 (dd, 1 H,
NMR (400 MHz, CDCl ): l 6.50 (br d, 1 H J
6.9
3
NH,C2
J3B,4B 9.7 Hz, H-3B), 4.20–4.08 (m, 3 H, 2B%, H-5A%,
OCH CHꢀCH ), 4.02 (dq, 1 H, H-5B%), 3.98–3.93 (m, 1
Hz, NHAc), 5.97 (dd, 1 H, J2C,3C 10.7, J3C,4C 9.1 Hz,
H-3C), 5.94–5.83 (m, 1 H, CHꢀCH ), 5.37 (d, 1 H,
2
2
2
H, OCH CHꢀCH ), 3.87 (dq, 1 H, H-5B), 1.97 (s, 3 H,
J
1C,2C
8.1 Hz, H-1C), 5.34 (dd, 1 H, J1A%,2A% 1.9, J2A%,3A%
2
2
CH , OAc), 1.41 (d, 3 H, J
6.2 Hz, H-6A), 1.18 (d,
3.4 Hz, H-2A%), 5.32 (dd, 1 H, J2A,3A 3.4, J3A,4A 10.0
3
5A,6A
3
H, J5A%,6A% 6.3 Hz, H-6A%), 1.13 (d, 3 H, J
6.3 Hz,
Hz, H-3A), 5.32–5.26 (m, 1 H, CHꢀCH ), 5.26 (dd, 1
5B,6B
1
2
3
H-6B), 0.92 (d, 3 H, J5B%,6B% 6.2 Hz, H-6B%); C NMR
100 MHz, CDCl ): l 169.11 (CꢀO, OAc), 168.13 and
H, J1A,2A 1.8 Hz, H-2A), 5.23–5.19 (m, 1 H, CHꢀCH2),
5.12–5.03 (m, 5 H, H-1A%, H-4A%, H-3B%, H-4B%, H-
4A), 5.00 (t, 1 H, J3B,4B=J4B,5B=9.9 Hz, H-4B), 4.97
(d, 1 H, J1B%,2B% 1.7 Hz, H-1B%), 4.90 (dd, 1 H, J4C,5C 10.1
Hz, H-4C), 4.76 (d, 1 H, J1A,2A 1.7 Hz, H-1A), 4.72 (d,
1 H, J1B,2B 1.4 Hz, H-1B), 4.23 (dd, 1 H, J6C,6%C 12.2,
J5C,6C 4.6 Hz, H-6C), 4.19 (dd, 1 H, J2A%,3A% 3.4, J3A%,4A%
9.9 Hz, H-3A%), 4.17–4.13 (m, 1 H, OCH CHꢀCH ),
(
1
3
65.85 (2×CꢀO, NPhth), 166.11–164.42 (10 C, 10×
CꢀO, OBz), 133.55–122.52 (67 C, Ar, CꢀCH ), 117.73
2
(
CꢀCH ), 99.93 (C-1B%), 99.78 (C-1C), 99.65 (C-1A%)
2
98.94 (C-1A), 98.26 (C-1B), 79.61 (C-2B), 77.49 (C-3B),
76.58 (C-2B%), 74.15 (C-4A%), 73.53 (C-3A%), 73.25 (C-
2A%), 72.37 (C-4B), 71.98 (C-5C), 71.94 (A-4), 71.65
2
2
(
C-4B%), 71.09 (2 C, C-3A and C-3C), 69.72 (2 C, C-2A
4.14 (dd, 1 H, J3B,4B 9.7 H-3B), 4.07 (dd, 1 H, J5C,6C 2.5
Hz, H-6%C), 4.02 (dq, 1 H, H-5B%), 4.01–3.95 (m, 1 H,
and C-4C), 69.59 (C-3B%), 68.10 (OCH CꢀCH ), 67.94
2
2
(
C-5A), 67.41 (C-5B%), 66.86 (C-5A%), 66.32 (C-5B),
OCH CHꢀCH ), 4.00 (dd, 1 H, J
3.3 Hz, H-2B),
2
2
2B,3B
6
1
2.81 (C-6C), 54.37 (C-2C), 20.62 (CH , OAc), 17.61,
3.91 (dd, 1 H H-2B), 3.89 (dq, 1 H, H-5A%), 3.83 (m, 1
H H-5A), 3.76 (ddd, 1 H, H-5C), 3.73 (dq, 1 H, H-5B),
2.74 (ddd, 1 H, H-2C), 2.25–1.87 (12 s, 36 H, 12×
3
7.53, 17.41 and 17.20 (4×CH , C-6A, C-6A%, C-6B%,
3
C-6B). MALDI MS Calcd for C113H101NNaO : m/z
34
2040.0; found m/z 2040.3. Anal. Calcd for
CH , 12 OAc), 1.24 (d, 3 H, J
6.1 Hz, H-6A), 1.22
3
5A,6A
C113H101NO : C, 67.29; H, 5.05; N, 0.69. Found: C,
(d, 3 H, J5B%,6B% 6.5 Hz, H-6B%), 1.17 (d, 3 H, J5A%,6A% 6.5
34
1
3
67.31; H, 5.06; N, 0.72.
Hz, H-6A%), 1.15 (d, 3 H, J5B,6B 6.4 Hz, H-6B);
C
Allyl 2,3,4-tri-O-acetyl-h-
L-rhamnopyranosyl-(12)-
NMR (100 MHz, CDCl ): l 171.61–169.50 (12 C,
3
3
,4-di-O-acetyl-h-
- rhamnopyranosyl - (12)-[3,4,6-tri-O-ace-
tyl-2-deoxy- 2-acetamido-i- -glucopyranosyl-(13)]-
L
-rhamnopyranosyl-(13)-2,4-di-O-
12×CꢀO, NHAc and 11×OAc), 133.51 (CꢀCH2),
acetyl - h -
L
117.70 (CꢀCH ), 99.56 (2 C, C-1A and C-1B%), 99.24
2
D
(C-1A%), 98.36 (C-1C), 98.13 (C-1B), 78.40 (C-2B),